Genomenon Honored as one of 50 Companies to Watch 2019

Mike Klein, CEO of Genomenon, as interviewed by Jeffrey Mosher, Operations Director of Michigan Business Network on Genomenon’s recent award as one of the Top 50 Companies to Watch in Michigan.

Read more

Don’t Call It a Comeback

Mark Kiel, Founder and Chief Science Officer of Genomenon, shares his comeback story at Startup Story Night 2019 at the Marble Bar in Detroit. Genomenon has come a very long way. Like any good story, we had our ups and downs, moments of excitement and fear while rapidly growing in a developing industry. Read about …

Read more

The Entirety of Genomic Literature, Now in Moon with Mastermind

A guest post from Peter Schols, CEO of Diploid: This week, our team at Diploid announced exciting news: We have integrated the Mastermind Genomic Search Engine into Moon to accelerate the diagnostic process for rare disease.

Read more

5 Key Considerations when Selecting a Variant Database

With millions of human genetic variants cited in over 30 million articles, comprehensively searching the medical research for a variant can be like finding a needle in a haystack. This is especially important when a single paper can mean the difference between a variant of uncertain significance (VUS) and a pathogenic variant.

Read more

Genomenon Research Report: Emerging Genomic Variants in 2018

2018 has been another banner year in the progression of Precision Medicine! Year over year, there has been a dramatic rise in the number of scientific studies and initiatives that resulted in meaningful published findings, and 2018 was another record-breaker. To demonstrate trends in genetics and genomics research seen through the lens of scientific publications, …

Read more

Genomic Variant Curation: “The Power of Zero”

As a parent, sometimes the most powerful answer you can give your children is “no”. Once they know where the boundaries are, they just might stop trying to navigate the gray area to find loopholes. The same can be said for genomic variant curation.

Read more